ERA-话题@MedSci

#ERA#

425篇内容 | 3092人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1739147, encodeId=034b1e39147af, content=<a href='/topic/show?id=6e566913df' target=_blank style='color:#2F92EE;'>#ERA#</a>, objectTitle=百奥赛图与LiberoThera共同开发全人GPCR抗体药物取得里程碑式进展, objectType=article, longId=732978, objectId=3ce1e32978e9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3ce1e32978e9, replyNumber=0, likeNumber=76, createdTime=2022-11-16, rootId=0, userName=124988c7m106暂无昵称, userId=e36234488643, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3ce1e32978e9, moduleTitle=百奥赛图与LiberoThera共同开发全人GPCR抗体药物取得里程碑式进展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3ce1e32978e9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1739127, encodeId=5b0c1e391270f, content=<a href='/topic/show?id=6e566913df' target=_blank style='color:#2F92EE;'>#ERA#</a>, objectTitle=Alz Res Therapy：脂钙蛋白，有利于诊断痴呆分型, objectType=article, longId=294477, objectId=fd492944e7d0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fd492944e7d0, replyNumber=0, likeNumber=94, createdTime=2022-10-29, rootId=0, userName=124988c7m106暂无昵称, userId=e36234488643, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fd492944e7d0, moduleTitle=Alz Res Therapy：脂钙蛋白，有利于诊断痴呆分型, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fd492944e7d0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1739123, encodeId=fd091e39123e3, content=<a href='/topic/show?id=6e566913df' target=_blank style='color:#2F92EE;'>#ERA#</a>, objectTitle=Journal Endovascular Therapy：DCB和BMS治疗股腘动脉病变，术后TLR发生率无差异？, objectType=article, longId=293597, objectId=44cf29359e24, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=44cf29359e24, replyNumber=0, likeNumber=78, createdTime=2022-04-05, rootId=0, userName=124988c7m106暂无昵称, userId=e36234488643, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=44cf29359e24, moduleTitle=Journal Endovascular Therapy：DCB和BMS治疗股腘动脉病变，术后TLR发生率无差异？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=44cf29359e24)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1739133, encodeId=71411e39133c2, content=<a href='/topic/show?id=6e566913df' target=_blank style='color:#2F92EE;'>#ERA#</a>, objectTitle=Ann Oncol：Ceralasertib (AZD6738)联合durvalumab（德瓦鲁单抗）治疗抗PD-1失败晚期/转移性黑色素瘤患者的疗效, objectType=article, longId=295681, objectId=0b9e295681bd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0b9e295681bd, replyNumber=0, likeNumber=75, createdTime=2022-08-01, rootId=0, userName=124988c7m106暂无昵称, userId=e36234488643, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0b9e295681bd, moduleTitle=Ann Oncol：Ceralasertib (AZD6738)联合durvalumab（德瓦鲁单抗）治疗抗PD-1失败晚期/转移性黑色素瘤患者的疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0b9e295681bd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1739110, encodeId=270c1e391109e, content=<a href='/topic/show?id=6e566913df' target=_blank style='color:#2F92EE;'>#ERA#</a>, objectTitle=2021 ACR：可靠性如何？OMERACT膝关节炎症MRI评分系统, objectType=article, longId=221163, objectId=c18e221163f1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c18e221163f1, replyNumber=0, likeNumber=86, createdTime=2022-10-05, rootId=0, userName=124988c7m106暂无昵称, userId=e36234488643, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c18e221163f1, moduleTitle=2021 ACR：可靠性如何？OMERACT膝关节炎症MRI评分系统, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c18e221163f1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1739083, encodeId=217b1e39083e2, content=<a href='/topic/show?id=6e566913df' target=_blank style='color:#2F92EE;'>#ERA#</a>, objectTitle=Alz Res Therapy：眼动跟踪任务，可预测额颞叶痴呆症的情感识别障碍, objectType=article, longId=220013, objectId=5d1f220013bb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5d1f220013bb, replyNumber=0, likeNumber=76, createdTime=2022-01-22, rootId=0, userName=124988c7m106暂无昵称, userId=e36234488643, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5d1f220013bb, moduleTitle=Alz Res Therapy：眼动跟踪任务，可预测额颞叶痴呆症的情感识别障碍, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5d1f220013bb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1739076, encodeId=a67d1e3907699, content=<a href='/topic/show?id=6e566913df' target=_blank style='color:#2F92EE;'>#ERA#</a>, objectTitle=Alz Res Therapy：脑脊液tau蛋白，助力认知功能分组, objectType=article, longId=219918, objectId=1011219918d2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1011219918d2, replyNumber=0, likeNumber=118, createdTime=2022-05-08, rootId=0, userName=124988c7m106暂无昵称, userId=e36234488643, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1011219918d2, moduleTitle=Alz Res Therapy：脑脊液tau蛋白，助力认知功能分组, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1011219918d2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1739072, encodeId=a3461e3907267, content=<a href='/topic/show?id=6e566913df' target=_blank style='color:#2F92EE;'>#ERA#</a>, objectTitle=Alz Res Therapy：白质高信号和痴呆影像指标，关系千丝万缕, objectType=article, longId=219881, objectId=2af22198811c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2af22198811c, replyNumber=0, likeNumber=75, createdTime=2022-07-23, rootId=0, userName=124988c7m106暂无昵称, userId=e36234488643, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2af22198811c, moduleTitle=Alz Res Therapy：白质高信号和痴呆影像指标，关系千丝万缕, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2af22198811c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1739128, encodeId=e6831e39128f2, content=<a href='/topic/show?id=6e566913df' target=_blank style='color:#2F92EE;'>#ERA#</a>, objectTitle=Alz Res Therapy：健康饮食，可降低痴呆风险, objectType=article, longId=294478, objectId=36622944e8ac, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=36622944e8ac, replyNumber=0, likeNumber=74, createdTime=2022-02-22, rootId=0, userName=124988c7m106暂无昵称, userId=e36234488643, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=36622944e8ac, moduleTitle=Alz Res Therapy：健康饮食，可降低痴呆风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=36622944e8ac)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1739138, encodeId=07bc1e3913811, content=<a href='/topic/show?id=6e566913df' target=_blank style='color:#2F92EE;'>#ERA#</a>, objectTitle=J Clin Oncol：选择性雌激素受体降解剂（Elacestrant）对比标准内分泌治疗ER+/HR-晚期乳腺癌的疗效：III期临床研究EMERALD, objectType=article, longId=727795, objectId=19a7e27795a3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=19a7e27795a3, replyNumber=0, likeNumber=88, createdTime=2022-10-25, rootId=0, userName=124988c7m106暂无昵称, userId=e36234488643, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=19a7e27795a3, moduleTitle=J Clin Oncol：选择性雌激素受体降解剂（Elacestrant）对比标准内分泌治疗ER+/HR-晚期乳腺癌的疗效：III期临床研究EMERALD, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=19a7e27795a3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1739149, encodeId=40611e39149a7, content=<a href='/topic/show?id=6e566913df' target=_blank style='color:#2F92EE;'>#ERA#</a>, objectTitle=Molecular Therapy : 关闭EBAG9基因，增强CAR-T效果, objectType=article, longId=733153, objectId=0a19e3315315, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0a19e3315315, replyNumber=0, likeNumber=68, createdTime=2022-10-05, rootId=0, userName=124988c7m106暂无昵称, userId=e36234488643, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0a19e3315315, moduleTitle=Molecular Therapy : 关闭EBAG9基因，增强CAR-T效果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0a19e3315315)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1739130, encodeId=10461e3913008, content=<a href='/topic/show?id=6e566913df' target=_blank style='color:#2F92EE;'>#ERA#</a>, objectTitle=Alz Res Therapy-神经丝轻链蛋白，可预测认知功能减退, objectType=article, longId=294523, objectId=efb3294523e8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=efb3294523e8, replyNumber=0, likeNumber=105, createdTime=2022-12-08, rootId=0, userName=124988c7m106暂无昵称, userId=e36234488643, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=efb3294523e8, moduleTitle=Alz Res Therapy-神经丝轻链蛋白，可预测认知功能减退, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=efb3294523e8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1739114, encodeId=9c051e3911425, content=<a href='/topic/show?id=6e566913df' target=_blank style='color:#2F92EE;'>#ERA#</a>, objectTitle=Alz Res Therapy：整合多组学，揭示神经系统的通路变化, objectType=article, longId=221464, objectId=fcae221464b8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fcae221464b8, replyNumber=0, likeNumber=72, createdTime=2022-06-16, rootId=0, userName=124988c7m106暂无昵称, userId=e36234488643, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fcae221464b8, moduleTitle=Alz Res Therapy：整合多组学，揭示神经系统的通路变化, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fcae221464b8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1739098, encodeId=931f1e390981c, content=<a href='/topic/show?id=6e566913df' target=_blank style='color:#2F92EE;'>#ERA#</a>, objectTitle=Theramex凭借治疗绝经症状的非激素型替代药物Femarelle®进军OTC市场, objectType=article, longId=220522, objectId=d8372205226a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d8372205226a, replyNumber=0, likeNumber=58, createdTime=2022-10-15, rootId=0, userName=124988c7m106暂无昵称, userId=e36234488643, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d8372205226a, moduleTitle=Theramex凭借治疗绝经症状的非激素型替代药物Femarelle®进军OTC市场, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d8372205226a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1739075, encodeId=c7eb1e39075c0, content=<a href='/topic/show?id=6e566913df' target=_blank style='color:#2F92EE;'>#ERA#</a>, objectTitle=Alz Res Therapy：随访20年，APOE ε4携带者，认知功能恶化更加严重, objectType=article, longId=219919, objectId=ec4a2199197f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ec4a2199197f, replyNumber=0, likeNumber=74, createdTime=2022-06-09, rootId=0, userName=124988c7m106暂无昵称, userId=e36234488643, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ec4a2199197f, moduleTitle=Alz Res Therapy：随访20年，APOE ε4携带者，认知功能恶化更加严重, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ec4a2199197f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1739131, encodeId=d1551e391319f, content=<a href='/topic/show?id=6e566913df' target=_blank style='color:#2F92EE;'>#ERA#</a>, objectTitle=Alz Res Therapy：阿尔兹海默治疗，人工智能助力“老药新用”, objectType=article, longId=294524, objectId=0ad12945241a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0ad12945241a, replyNumber=0, likeNumber=79, createdTime=2022-10-11, rootId=0, userName=124988c7m106暂无昵称, userId=e36234488643, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0ad12945241a, moduleTitle=Alz Res Therapy：阿尔兹海默治疗，人工智能助力“老药新用”, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0ad12945241a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1739115, encodeId=751b1e3911515, content=<a href='/topic/show?id=6e566913df' target=_blank style='color:#2F92EE;'>#ERA#</a>, objectTitle=Alz Res Therapy：右颞中叶糖代谢，或提示主观认知减退, objectType=article, longId=221465, objectId=3c8f221465b9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3c8f221465b9, replyNumber=0, likeNumber=88, createdTime=2022-05-09, rootId=0, userName=124988c7m106暂无昵称, userId=e36234488643, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3c8f221465b9, moduleTitle=Alz Res Therapy：右颞中叶糖代谢，或提示主观认知减退, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3c8f221465b9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1739077, encodeId=87171e39077c1, content=<a href='/topic/show?id=6e566913df' target=_blank style='color:#2F92EE;'>#ERA#</a>, objectTitle=Alz Res Therapy：胆碱酯酶抑制剂使用，或和认知功能变化无关, objectType=article, longId=219920, objectId=b0cf219920d6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b0cf219920d6, replyNumber=0, likeNumber=134, createdTime=2022-03-13, rootId=0, userName=124988c7m106暂无昵称, userId=e36234488643, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b0cf219920d6, moduleTitle=Alz Res Therapy：胆碱酯酶抑制剂使用，或和认知功能变化无关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b0cf219920d6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1739118, encodeId=34971e3911889, content=<a href='/topic/show?id=6e566913df' target=_blank style='color:#2F92EE;'>#ERA#</a>, objectTitle=Alz Res Therap：痴呆患者，患新冠后有何临床特点？, objectType=article, longId=221541, objectId=122122154185, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=122122154185, replyNumber=0, likeNumber=68, createdTime=2022-01-09, rootId=0, userName=124988c7m106暂无昵称, userId=e36234488643, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=122122154185, moduleTitle=Alz Res Therap：痴呆患者，患新冠后有何临床特点？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=122122154185)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1739100, encodeId=83f71e391005f, content=<a href='/topic/show?id=6e566913df' target=_blank style='color:#2F92EE;'>#ERA#</a>, objectTitle=Aimmune Therapeutics在EAACI PAAM数字会议上呈报长期每日口服免疫治疗药物PALFORZIA®（花生过敏原粉剂-dnfp）的免疫学结果新数据, objectType=article, longId=220575, objectId=ad652205e545, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ad652205e545, replyNumber=0, likeNumber=79, createdTime=2021-11-27, rootId=0, userName=124988c7m106暂无昵称, userId=e36234488643, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ad652205e545, moduleTitle=Aimmune Therapeutics在EAACI PAAM数字会议上呈报长期每日口服免疫治疗药物PALFORZIA®（花生过敏原粉剂-dnfp）的免疫学结果新数据, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ad652205e545)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

ERA

2020-05-29

124988c7m106暂无昵称 (审核中...)

前往app查看评论内容

#ERA#

百奥赛图与LiberoThera共同开发全人GPCR抗体药物取得里程碑式进展

2022-11-16

124988c7m106暂无昵称 (审核中...)

前往app查看评论内容

#ERA#

Alz Res Therapy：脂钙蛋白，有利于诊断痴呆分型

2022-10-29

124988c7m106暂无昵称 (审核中...)

前往app查看评论内容

#ERA#

Journal Endovascular Therapy：DCB和BMS治疗股腘动脉病变，术后TLR发生率无差异？

2022-04-05

124988c7m106暂无昵称 (审核中...)

前往app查看评论内容

#ERA#

Ann Oncol：Ceralasertib (AZD6738)联合durvalumab（德瓦鲁单抗）治疗抗PD-1失败晚期/转移性黑色素瘤患者的疗效

2022-08-01

124988c7m106暂无昵称 (审核中...)

前往app查看评论内容

#ERA#

2021 ACR：可靠性如何？OMERACT膝关节炎症MRI评分系统

2022-10-05

124988c7m106暂无昵称 (审核中...)

前往app查看评论内容

#ERA#

Alz Res Therapy：眼动跟踪任务，可预测额颞叶痴呆症的情感识别障碍

2022-01-22

124988c7m106暂无昵称 (审核中...)

前往app查看评论内容

#ERA#

Alz Res Therapy：脑脊液tau蛋白，助力认知功能分组

2022-05-08

124988c7m106暂无昵称 (审核中...)

前往app查看评论内容

#ERA#

Alz Res Therapy：白质高信号和痴呆影像指标，关系千丝万缕

2022-07-23

124988c7m106暂无昵称 (审核中...)

前往app查看评论内容

#ERA#

Alz Res Therapy：健康饮食，可降低痴呆风险

2022-02-22

124988c7m106暂无昵称 (审核中...)

前往app查看评论内容

#ERA#

J Clin Oncol：选择性雌激素受体降解剂（Elacestrant）对比标准内分泌治疗ER+/HR-晚期乳腺癌的疗效：III期临床研究EMERALD

2022-10-25

124988c7m106暂无昵称 (审核中...)

前往app查看评论内容

#ERA#

Molecular Therapy : 关闭EBAG9基因，增强CAR-T效果

2022-10-05

124988c7m106暂无昵称 (审核中...)

前往app查看评论内容

#ERA#

Alz Res Therapy-神经丝轻链蛋白，可预测认知功能减退

2022-12-08

124988c7m106暂无昵称 (审核中...)

前往app查看评论内容

#ERA#

Alz Res Therapy：整合多组学，揭示神经系统的通路变化

2022-06-16

124988c7m106暂无昵称 (审核中...)

前往app查看评论内容

#ERA#

Theramex凭借治疗绝经症状的非激素型替代药物Femarelle®进军OTC市场

2022-10-15

124988c7m106暂无昵称 (审核中...)

前往app查看评论内容

#ERA#

Alz Res Therapy：随访20年，APOE ε4携带者，认知功能恶化更加严重

2022-06-09

124988c7m106暂无昵称 (审核中...)

前往app查看评论内容

#ERA#

Alz Res Therapy：阿尔兹海默治疗，人工智能助力“老药新用”

2022-10-11

124988c7m106暂无昵称 (审核中...)

前往app查看评论内容

#ERA#

Alz Res Therapy：右颞中叶糖代谢，或提示主观认知减退

2022-05-09

124988c7m106暂无昵称 (审核中...)

前往app查看评论内容

#ERA#

Alz Res Therapy：胆碱酯酶抑制剂使用，或和认知功能变化无关

2022-03-13

124988c7m106暂无昵称 (审核中...)

前往app查看评论内容

#ERA#

Alz Res Therap：痴呆患者，患新冠后有何临床特点？

2022-01-09

124988c7m106暂无昵称 (审核中...)

前往app查看评论内容

#ERA#

Aimmune Therapeutics在EAACI PAAM数字会议上呈报长期每日口服免疫治疗药物PALFORZIA®（花生过敏原粉剂-dnfp）的免疫学结果新数据

2021-11-27

科室
- - 订阅+
  - 更多科室
工具
服务